Welcome to LookChem.com Sign In|Join Free
  • or
N-(4-Methoxyphenyl)-4-methyl-1-phenyl-1H-pyrazol-3-amine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

103174-19-2

Post Buying Request

103174-19-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103174-19-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 103174-19-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,1,7 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 103174-19:
(8*1)+(7*0)+(6*3)+(5*1)+(4*7)+(3*4)+(2*1)+(1*9)=82
82 % 10 = 2
So 103174-19-2 is a valid CAS Registry Number.

103174-19-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(4-Methoxyphenyl)-4-methyl-1-phenyl-1H-pyrazol-3-amine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103174-19-2 SDS

103174-19-2Relevant academic research and scientific papers

Multi-cyclic compound and method of use

-

Page/Page column 22-23, (2010/11/28)

The present invention relates to chemical compounds having a general formula I wherein A, B, C1, C2, D, L1, L2 and R3-4 are defined herein, and synthetic intermediates, which are capable of modulating various protein kinase receptor enzymes and, thereby, influencing various disease states and conditions related to the activities of such kinases. For example, the compounds are capable of modulating Tie-2 and Aurora kinase enzymes thereby influencing angiogenesis and the process of cell cycle and cell proliferation, respectively, to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of various protein kinases.

Anti-inflammator 1,n-diarylpyrazol-3-amines

-

, (2008/06/13)

There are described compounds of formula I, STR1 in which either R2 represents hydrogen, alkyl or Ar2, and R3 represents hydrogen, alkyl or alkyl substituted by Ar3 ; or R2 and R3 together

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 103174-19-2